• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Pregnancy and Postpartum Course
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » medication

Articles Tagged with ''medication''

shutterstock_2425592969.jpg

Throwback Benzos

February 15, 2024
Chris Aiken, MD and Kellie Newsome, PMHNP

The release of the fast-acting antidepressant Auvelity got us thinking about an older strategy to speed up antidepressants: benzodiazepines. So we're bringing you this Thursday throwback, do benzodiazepines treat depression? Benzos and sleep meds rarely earn a mention in textbooks on depression these days, but that has not always been the case. (Part 1 of a 2 part series)


Read More
shutterstock_137226314.jpg

Auvelity: 4 Controversies

February 12, 2024
Chris Aiken, MD and Kellie Newsome, PMHNP

Auvelity, a new rapid acting medication for depression, is a branded combination of two generic drugs. We look at its side effects, addictive potential, and whether you can just use the generic components.


Read More
shutterstock_571617067.jpg

Auvelity A Fast Acting Antidepressant

February 5, 2024
Chris Aiken, MD and Kellie Newsome, PMHNP

Auvelity, a new rapid acting medication for depression, is a branded combination of two generic drugs. We look at how it works and the clinical trials, including new data in treatment resistant depression



Read More
canstockphoto12099447.jpg
Expert Q&A

Management of Aggressive Behavior in Children and Adolescents on the Inpatient Unit and Emergency Department

August 1, 2023
Vera Feuer, MD
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

CHPR_QA1_Feuer_Headshot.jpgVera Feuer, MD.

Director, Pediatric Emergency Psychiatry and Behavioral Health Urgent Care, Cohen Children’s Medical Center; Associate Professor, Psychiatry, Pediatrics and Emergency Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY. 

Dr. Feuer has no financial relationships with companies related to this material.

CLINICAL UPDATE

Medications to Treat OCD: What Psychotherapists Need to Know

July 3, 2023
Jessica Goren, PharmD.
From The Carlat Psychotherapy Report
Issue Links: Editorial Information

Jessica L Goren, PharmD. Instructor in Psychiatry, Cambridge Health Alliance.

Dr. Goren has no financial relationships with companies related to this material. 

Learn about common medications for OCD, including SSRIs and clomipramine, along with their side effects, as well as the role of CBT and augmentation strategies in treatment.


Read More
TCPR_July2023_manwithmedication_thumb.jpg
Expert Q&A

Prescription Drug Misuse

July 3, 2023
Joseph Pierre, MD.
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

JoePierreMD_thumb.jpgJoseph Pierre, MD.

Clinical Professor, Department of Psychiatry and Behavioral Sciences, University of California, San Francisco.

Dr. Pierre has no financial relationships with companies related to this material.

Medication misuse requires more than telling your patient, “Just say no.” Dr. Pierre shows us how to keep the conversation firm but therapeutic.


Read More

Does Pioglitazone Lead to Reduced Alcohol Use?

July 1, 2022
Deepti Anbarasan, MD. and Nicholas Apping, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Nicholas Apping, MD, and Deepti Anbarasan. 

MD. Dr. Apping and Dr. Anbarasan, authors for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

The hunt continues for effective medications for alcohol use disorder. Researchers here investigated the potential utility pioglitazone, a medication commonly used for diabetes management. 


Read More

Medications for Alcohol Use Disorder: An Overview

March 1, 2022
Mikveh Warshaw, NP.
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Mikveh Warshaw, NP. Psychiatric mental health nurse practitioner, Community Health Center Inc. and faculty member of Center for Key Populations (CKP) Program, Middletown, CT. Ms. Warshaw has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
There are three FDA approved medications for alcohol use disorder (AUD) and many others that have been tested. Here, we summarize the evidence behind the various medications for alcohol use disorder and highlight clinical scenarios in which each should be considered.
Read More
CLINICAL UPDATE

Prescribing to Children of Divorce

March 12, 2021
Anthony Charuvastra, MD.
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Anthony Charuvastra, MD. Adjunct Assistant Professor, NYU Langone Medical Center Department of Child and Adolescent Psychiatry. Dr. Charuvastra has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
What is the best approach to effective clinical care with families that are separated or divorced? This article covers the complexities, the legalities, and an expectation of collaboration that can help us to help children to receive good mental health care despite the inevitable differences between parents in these situations.
Read More

Buspirone: Still Effective After All These Years?

February 3, 2021
Eugene Rubin, MD.
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Eugene Rubin, MD. Psychiatrist in private practice, Bingham Farms, MI. Dr. Rubin has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Buspirone (Buspar) is approved for generalized anxiety disorder, but its efficacy there is often questioned. Here we find out how it stacks up against the benzos and SSRIs, and explore its off-label potential in depression, sexual dysfunction, alcoholism, traumatic brain injury, and premenstrual dysphoric disorder.
Read More
Previous 1 2 3 4 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • GFB1e_Spiral.png

    Geriatric Psychiatry Fact Book, First Edition (2025)

    Everything you need to help your older adult patients from the unbiased clinical experts who...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2669706505.jpg
    General Psychiatry

    A New Ketamine

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.